Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges.

ABSTRACT: The recent coronavirus disease-2019 (COVID-19) outbreak has increased at an alarming rate, representing a substantial cause of mortality worldwide. Respiratory injuries are major COVID-19 related complications, leading to poor lung circulation, tissue scarring, and airway obstruction. Despite an in-depth investigation of respiratory injury's molecular pathogenesis, effective treatments have yet to be developed. Moreover, early detection of viral infection is required to halt the disease-related long-term complications, including respiratory injuries. The currently employed detection technique (quantitative real-time polymerase chain reaction or qRT-PCR) failed to meet this need at some point because it is costly, time-consuming, and requires higher expertise and technical skills. Polymer-b

SUBMITTER: Rana MM 

PROVIDER: S-EPMC8054481 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature